Philips | PHIA - Sales Revenues

Stock Price
23.52
Daily Change
0.23 0.99%
Monthly
0.51%
Yearly
5.85%
Q2 Forecast
22.79

Philips reported EUR5.1B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
ABB USD 8.73B 322M Mar/2026
Abbott USD 11.16B 300M Mar/2026
Aena EUR 1.59B 200M Dec/2025
Alcon AG USD 2.7B 110M Dec/2025
ASM International NV EUR 862.5M 164.2M Mar/2026
ASML Holding EUR 8.77B 951M Mar/2026
AstraZeneca USD 15.5B 313M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
Boston Scientific USD 5.2B 90M Mar/2026
Demant DKK 6.26B 810M Dec/2025
EDAP TMS EUR 13.88M 2.16M Sep/2025
Edwards Lifesciences USD 1.65B 80M Mar/2026
Essilor EUR 14.47B 7.6B Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Geberit CHF 715.4M 67.1M Dec/2025
Getinge SEK 11.07B 3.2B Dec/2024
GN Store Nord DKK 4.68B 720M Dec/2025
GRIFOLS EUR 1.98B 110M Dec/2025
HeidelbergCement EUR 11.06B 5.38B Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
Koninklijke Philips EUR 5.93B 905.95M Dec/2025
Legrand EUR 2.51B 320M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Medtronic USD 9B 39M Jan/2026
Merck EUR 5.25B 70M Dec/2025
Philips EUR 5.1B 797M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
SAP EUR 9.56B 120M Mar/2026
Schneider Electric EUR 11.1B 1.38B Dec/2025
Smith & Nephew USD 3.18B 353M Dec/2025
Trinity Biotech USD 14.31M 1.55M Sep/2025